Clinical Trial Update: Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update investigating zoledronic acid in combination with aromatase inhibitors as adjuvant therapy for breast cancer in Phase 2 and Phase 3; curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromatase inhibitors (aromatase inhibitor)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Tianjin Medical University | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: UNKNOWN